Severe pediatric asthma with a poor response to omalizumab: a report of three cases and three-dimensional bronchial wall analysis

Omalizumab is used for the treatment of persistent severe allergic asthma in adults and children. However, some patients remain symptomatic even after omalizumab treatment. In bronchial asthma, chronic inflammation of the bronchial wall causes thickening of the airway wall, resulting from irreversib...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuge, Mitsuru, Ikeda, Masanori, Kondo, Yoichi, Tsukahara, Hirokazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743945/
https://www.ncbi.nlm.nih.gov/pubmed/34994237
http://dx.doi.org/10.1177/03000605211070492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743945/
https://www.ncbi.nlm.nih.gov/pubmed/34994237
http://dx.doi.org/10.1177/03000605211070492

Ejemplares similares